BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32158324)

  • 1. What Else Can We Use in The Discrimination of Activated MS Plaques in Addition to Diffusion MRI?
    Karaman A
    Eurasian J Med; 2020 Feb; 52(1):98-99. PubMed ID: 32158324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Pharmacological Approach to ARDS: The Place of Bosentan.
    Araz O
    Eurasian J Med; 2020 Feb; 52(1):81-85. PubMed ID: 32158321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute respiratory distress syndrome: pharmacological treatment options in development.
    Hite RD; Morris PE
    Drugs; 2001; 61(7):897-907. PubMed ID: 11434447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult respiratory distress syndrome (ARDS): the basics.
    Lechin AE; Varon J
    J Emerg Med; 1994; 12(1):63-8. PubMed ID: 8163809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Respiratory Distress Syndrome: Diagnosis and Management.
    Saguil A; Fargo MV
    Am Fam Physician; 2020 Jun; 101(12):730-738. PubMed ID: 32538594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute respiratory distress syndrome.
    Mortelliti MP; Manning HL
    Am Fam Physician; 2002 May; 65(9):1823-30. PubMed ID: 12018805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.
    Gatfield J; Mueller Grandjean C; Sasse T; Clozel M; Nayler O
    PLoS One; 2012; 7(10):e47662. PubMed ID: 23077657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.
    Sabaa N; de Franceschi L; Bonnin P; Castier Y; Malpeli G; Debbabi H; Galaup A; Maier-Redelsperger M; Vandermeersch S; Scarpa A; Janin A; Levy B; Girot R; Beuzard Y; Leboeuf C; Henri A; Germain S; Dussaule JC; Tharaux PL
    J Clin Invest; 2008 May; 118(5):1924-33. PubMed ID: 18382768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan as rescue treatment in refractory hypoxemia and pulmonary hypertension in a patient with ARDS and H7N9 influenza virus infection.
    Guo Q; Huang JA; Fraidenburg DR
    Lung; 2014 Oct; 192(5):635-6. PubMed ID: 24898108
    [No Abstract]   [Full Text] [Related]  

  • 10. Synopsis of Clinical Acute Respiratory Distress Syndrome (ARDS).
    Mane A; Isaac N
    Adv Exp Med Biol; 2021; 1304():323-331. PubMed ID: 34019275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adult respiratory distress syndrome.
    Sprung CL; Pons G; Elser B; Hauser MJ
    Postgrad Med; 1983 Jul; 74(1):253-61. PubMed ID: 6346298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial.
    Hostettler K; Baty F; Kleiner R; Junker L; Tamm M; Brutsche M
    Swiss Med Wkly; 2018 Oct; 148():w14677. PubMed ID: 30378090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chest radiography versus lung ultrasound for identification of acute respiratory distress syndrome: a retrospective observational study.
    See KC; Ong V; Tan YL; Sahagun J; Taculod J
    Crit Care; 2018 Aug; 22(1):203. PubMed ID: 30119687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition.
    Riviello ED; Kiviri W; Twagirumugabe T; Mueller A; Banner-Goodspeed VM; Officer L; Novack V; Mutumwinka M; Talmor DS; Fowler RA
    Am J Respir Crit Care Med; 2016 Jan; 193(1):52-9. PubMed ID: 26352116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Respiratory Distress Syndrome and COVID-19: A Literature Review.
    Hussain M; Khurram Syed S; Fatima M; Shaukat S; Saadullah M; Alqahtani AM; Alqahtani T; Bin Emran T; Alamri AH; Barkat MQ; Wu X
    J Inflamm Res; 2021; 14():7225-7242. PubMed ID: 34992415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.
    Pearl JM; Wellmann SA; McNamara JL; Lombardi JP; Wagner CJ; Raake JL; Nelson DP
    Ann Thorac Surg; 1999 Nov; 68(5):1714-21; discussion 1721-2. PubMed ID: 10585047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective cohort study of ALI/ARDS in the Tohoku district of Japan (second report).
    Endo S; Shibata S; Sato N; Hashiba E; Tajimi K; Saito K; Kawamae K; Nakane M; Murakawa M;
    J Anesth; 2010 Jun; 24(3):351-8. PubMed ID: 20349197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment.
    Fan E; Brodie D; Slutsky AS
    JAMA; 2018 Feb; 319(7):698-710. PubMed ID: 29466596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats.
    Besse S; Tanguy S; Riou B; Boucher F; Bulteau AL; Le Page C; Swynghedauw B; de Leiris J
    Eur J Pharmacol; 2001 Dec; 432(2-3):167-75. PubMed ID: 11740953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute respiratory distress syndrome after early successful primary percutaneous coronary intervention therapy in acute myocardial infarction: a case report.
    Su HM; Voon WC; Lin TH; Chu CS; Sheu SH; Lai WT
    Kaohsiung J Med Sci; 2005 Feb; 21(2):78-83. PubMed ID: 15825693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.